Bristol-Myers Squibb Company
ANTIBODIES AGAINST TIM3 AND USES THEREOF

Last updated:

Abstract:

Provided herein are antibodies, or antigen-binding portions thereof, that bind to T-cell immunoglobulin and mucin-domain containing-3 (TIM3) protein. Also provided are uses of these antibodies, or antigen-binding portions thereof, in therapeutic applications, such as treatment of cancer. Further provided are cells that produce the antibodies, or antigen-binding portions thereof, polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof, and vectors comprising the polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof.

Status:
Application
Type:

Utility

Filling date:

27 Nov 2019

Issue date:

18 Jun 2020